Individual factorsincluding baseline metabolic rate, GLP-1 receptor expression, and gut microbiota compositionmay influence both efficacy and side effect tolerance
Acetyl-L-carnitine crosses the blood-brain barrier, supporting acetylcholine synthesisa key neurotransmitter that improves communication between nerve cells
It is worth mentioning that the concept of thrombo-inflammation in atherosclerosis was proposed recently, which means that cell adhesion molecules not only accelerate the atherosclerotic process but also promote thrombosis (80)
Setti, G
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments